Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Sudish Murthy, MD, is the Surgical Director of the Center of Major Airway Disease and a staff thoracic surgeon in the Department of Thoracic and Cardiovascular Surgery, Sydell and Arnold Miller Family Heart & Vascular Institute. He holds joint appointments with the Transplant Center and the Taussig Cancer Institute. Currently, Dr. Murthy is the NetWork Chair of the Interventional Chest/Diagnostic Procedure NetWork. He is board-certified in general surgery and thoracic surgery.
His specialty interests include esophageal surgery; minimally invasive surgery including Robotics, bronchoscopic, laparoscopic and thorascopic procedures; general thoracic surgery and lung transplantation
Dr. Murthy earned his medical degree from Columbia University College of Physicians and Surgeons and a Ph.D. in pathology from the University of British Columbia, Vancouver, BC. At Columbia he received the Janeway Prize for Top Achievement in his graduating class, the Loeb Award for Excellence in Medicine, and the Merck Award for Outstanding Scholarship, among several other awards.
He completed an internship and a residency in surgery at Brigham and Women’s Hospital of Harvard University, Boston, continuing there for a residency in cardiothoracic surgery. As a Harvard University Clinical Fellow he was selected as the Whitman Travelling scholar and served as the surgical emissary for Harvard Medical School in the Department of Esophageal Surgery at Queen Mary Hospital Medical Center at the University of Hong Kong.
A dedicated researcher and prolific writer, Dr. Murthy has authored or co-authored more than 100 scientific articles in leading peer-reviewed medical journals and more than a dozen chapters in medical textbooks. His research interests include lung cancer, lung transplant and emphysema.
Dr. Murthy is a member of the Society of Thoracic Surgeons, American Association for Thoracic Surgery, American College of Surgeons, and is a fellow of the American College of Chest Physicians. He is also a member of the General Thoracic Surgical Club and Esophageal Surgical Club.
esophageal, pulmonary, mediastinal, chest wall and diaphragm surgery, minimally-invasive, lung volume reduction surgery, lung transplant surgery, general thoracic surgery, lung cancer surgery, esophageal cancer surgery
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/31/2013, Dr. Murthy has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.